Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignancies, Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02996214
What this trial is testing

Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)

Who this might be right for
Squamous Non-small-cell Lung Cancer
Nanjing Luye Sike Pharmaceutical Co., Ltd. 536
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Not applicableNot Yet RecruitingNCT07150598
What this trial is testing

Immune-Marker Platform for Patients With Advanced Lung Cancer

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC Stage IIIB~IVNSCLC Non-small Cell Lung Cancer
Technische Universität Dresden 500
Large-scale testing (Phase 3)Active Not RecruitingNCT06031558
What this trial is testing

Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Shouyao Holdings (Beijing) Co. LTD 120
Testing effectiveness (Phase 2)Looking for participantsNCT05271916
What this trial is testing

First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Shanghai Chest Hospital 140
Not applicableStudy completedNCT00864266
What this trial is testing

Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Carcinoma
European Lung Cancer Working Party 70
Post-approval studies (Phase 4)UnknownNCT02195453
What this trial is testing

Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Shandong Cancer Hospital and Institute 520
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Not applicableStudy completedNCT02619929
What this trial is testing

Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria

Who this might be right for
Non-Small-Cell Lung CancerBreast Cancer
Pierre Fabre Pharma GmbH 108
Testing effectiveness (Phase 2)Study completedNCT03090737
What this trial is testing

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 129
Testing effectiveness (Phase 2)UnknownNCT06590194
What this trial is testing

PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Suzhou Puhe Pharmaceutical Technology Co., LTD 96
Not applicableLooking for participantsNCT07174388
What this trial is testing

An External Control Arm Study in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
N-Power Medicine 650
Testing effectiveness (Phase 2)Ended earlyNCT05513703
What this trial is testing

Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
AbbVie 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Early research (Phase 1)Study completedNCT05639751
What this trial is testing

PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancers+1 more
Prelude Therapeutics Incorporated 135
Not applicableUnknownNCT04137588
What this trial is testing

Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Advanced Non-squamous Non-small Cell Lung Cancer
Peking University Cancer Hospital & Institute 126
Early research (Phase 1)Ended earlyNCT00424840
What this trial is testing

Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy

Who this might be right for
Lung Cancer
University of Massachusetts, Worcester 12
Testing effectiveness (Phase 2)Looking for participantsNCT07158489
What this trial is testing

Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC

Who this might be right for
NSCLCNSCLC (Advanced Non-small Cell Lung Cancer)
Swiss Cancer Institute 47
Testing effectiveness (Phase 2)Study completedNCT00297089
What this trial is testing

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerNSCLCNon-Small-Cell Lung Cancer
AbbVie (prior sponsor, Abbott) 165
Large-scale testing (Phase 3)UnknownNCT01303926
What this trial is testing

Quality of Life Comparison in Advanced Non-squamous Non Small Cell Lung Cancer

Who this might be right for
Non-squamous Nonsmall Cell Neoplasm of Lung
Gruppo Oncologico Italia Meridionale 118
Next Page